Literature DB >> 3485835

The macrophage-mediated regulation of hepatocyte synthesis of antithrombin III and alpha 1-proteinase inhibitor.

M Hoffman, H E Fuchs, S V Pizzo.   

Abstract

Antithrombin III (ATIII) is an anticoagulant protein which binds and inactivates thrombin and other serine proteinases. Little is known about regulation of its synthesis. We confirm that ATIII is synthesized by isolated rat hepatocytes, and that its synthesis is not altered by direct feedback of its complexes with proteinases. Neither is hepatocyte synthesis of ATIII altered by supernatants from macrophages cultured in the presence of ATIII-proteinase complexes. However, culture of macrophages with fibrinogen fragment D results in production of a factor(s) in the macrophage supernatants which stimulates hepatic fibrinogen synthesis, as previously described, and also stimulates the synthesis of ATIII and alpha 1-proteinase inhibitor (alpha 1PI). Synthesis of albumin and rat alpha 2-macroglobulin (alpha 2M) is not (alpha 2M) is not altered. Culture of macrophages in the presence of bacterial endotoxin also results in release of a factor(s) into the medium which stimulates the same changes in hepatocyte protein synthesis. These results show for the first time a mechanism by which synthesis of ATIII can be regulated during coagulation and fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485835     DOI: 10.1016/0049-3848(86)90368-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Relationship between angiotensinogen, alpha 1-protease inhibitor elastase complex, antithrombin III and C-reactive protein in septic ARDS.

Authors:  U Hilgenfeldt; W Kellermann; G Kienapfel; M Jochum
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Anti-inflammatory drugs modulate histamine release from mast cells induced by fibrinogen degradation products.

Authors:  E Wojtecka-Lukasik; J Stachurska; M Kopeć; S Maśliński
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.